News stories about Mazor Robotics (NASDAQ:MZOR) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Mazor Robotics earned a media sentiment score of 0.14 on Accern’s scale. Accern also assigned news headlines about the medical instruments supplier an impact score of 45.9192577605098 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Mazor Robotics (NASDAQ MZOR) traded down 1.41% on Friday, reaching $37.09. The company had a trading volume of 116,131 shares. The company’s market capitalization is $894.35 million. Mazor Robotics has a 12 month low of $20.19 and a 12 month high of $45.64. The company’s 50 day moving average price is $38.68 and its 200-day moving average price is $32.88.
Mazor Robotics (NASDAQ:MZOR) last released its quarterly earnings data on Tuesday, August 1st. The medical instruments supplier reported ($0.16) EPS for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.09. The business had revenue of $15.46 million during the quarter, compared to the consensus estimate of $15.38 million. Mazor Robotics had a negative return on equity of 28.51% and a negative net margin of 37.66%. The firm’s revenue was up 86.7% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.09) earnings per share. On average, equities analysts predict that Mazor Robotics will post ($0.77) earnings per share for the current fiscal year.
Several equities research analysts have weighed in on MZOR shares. JMP Securities lowered Mazor Robotics from an “outperform” rating to a “market perform” rating in a research report on Friday, May 12th. They noted that the move was a valuation call. Needham & Company LLC reaffirmed a “hold” rating on shares of Mazor Robotics in a research report on Thursday, July 6th. Ladenburg Thalmann Financial Services reaffirmed a “buy” rating and issued a $46.00 target price on shares of Mazor Robotics in a research report on Monday, June 12th. Zacks Investment Research lowered Mazor Robotics from a “hold” rating to a “sell” rating in a report on Tuesday, July 18th. Finally, Wells Fargo & Company lowered Mazor Robotics from an “outperform” rating to a “market perform” rating in a report on Thursday, May 11th. One analyst has rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $36.00.
TRADEMARK VIOLATION NOTICE: “Mazor Robotics (NASDAQ:MZOR) Earning Somewhat Favorable Press Coverage, Analysis Shows” was first published by Rincon Hill News and is owned by of Rincon Hill News. If you are reading this news story on another website, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The legal version of this news story can be read at https://rinconhillneighbors.org/2017/08/19/mazor-robotics-nasdaqmzor-receiving-somewhat-favorable-media-coverage-accern-reports-updated-updated.html.
About Mazor Robotics
Mazor Robotics Ltd is an Israel-based medical device company that develops and markets surgical guidance systems and complementary products. It develops computerized and imaging-based systems in the field of spine surgery. Its products include: Renaissance Surgical Guidance System, which enables surgeons to advance from freehand surgical procedures to guided procedures, as well as Food and Drug Administration (FDA)-cleared and European Conformity (CE)-marked Renaissance System, used in spine surgeries, whether open or minimally invasive, for a number of clinical indications.
Receive News & Ratings for Mazor Robotics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mazor Robotics Ltd. and related companies with our FREE daily email newsletter.